InsiderTrades

Form 4 for PHR Phreesia, Inc.

Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001562180-23-003442 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2023-04-05 2023-04-03 PHR Smith Mark Douglas Dir S - Sale+OE $30.77 -7,000 16.6K -30% -$215.4K
DT 2023-04-05 2023-04-03 PHR Smith Mark Douglas Dir M - OptEx $4.71 +7,000 23.1K +43% +$33.0K
DT 2023-04-05 2023-04-03 PHR Smith Mark Douglas Dir M - OptEx $0.00 -7,000 65.2K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-03 S D 500 $31.77 16,112 D — — (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $31.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2 Common Common Stock 2023-04-03 S D 6,500 $30.69 16,612 D — — (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $31.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Common Common Stock 2023-04-03 M A 7,000 $4.71 23,112 D — —
4 Derivative Stock Option 2023-04-03 M D 7,000 $0.00 65,193 D $4.71 · — to 2028-09-04 7,000 Common Stock (F4) 27,306 of the original 84,193 shares underlying the option vested became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019, and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter.